This information was published on 2026-03-26T04:44:49 for IP Right Filed Published.
| Field | Value |
| (210) | 2639134 (IR 1908904) |
| (220) |
13 Feb 2026
|
| (300) |
DK, 06 Feb 2026, VA 2026 00217
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for weight reduction and long term weight loss maintenance; pharmaceutical preparations for the treatment of liver diseases; pharmaceutical preparations for the treatment of cardiovascular diseases, chronic kidney disease, heart failure and hypertension; pharmaceutical preparations for the treatment of neurodegenerative disorders and diseases. |
| (540) | Kyinsu |
| (550) | Word |
| (730) |
Novo Nordisk A/S
|
Find out more about publications on the About page.